The malaria sporozoite injected by a mosquito migrates to the liver by traversing host cells. The sporozoite also traverses hepatocytes before invading a terminal hepatocyte and developing into exoerythrocytic forms. Hepatocyte infection is critical for parasite development into merozoites that infect erythrocytes, and the sporozoite is thus an important target for antimalarial intervention. Here, we investigated two abundant sporozoite proteins of the most virulent malaria parasite Plasmodium falciparum and show that they play important roles during cell traversal and invasion of human hepatocytes. Incubation of P. falciparum sporozoites with R1
| BACKGROUND
Malaria is transmitted in 95 countries and territories, and approximately 2 billion people are at risk from being infected. This disease is caused by infection with Plasmodium parasites that, in 2015, were responsible for over 220 million clinical infections and approximately 630,000 deaths (Gething et al., 2016; WHO, 2015) . Of the six Plasmodium spp. that infect humans, P. falciparum is responsible for the majority of deaths, with most casualties involving pregnant women and young children living in sub-Saharan Africa (Gething et al., 2016; WHO, 2015) . Infection by malaria parasites begins with the injection of sporozoites into the skin of the human host by an infectious Anopheles mosquito. Sporozoites are transported to the liver by the blood and infect hepatocytes, each developing into thousands of merozoites per hepatocyte. Once differentiation into merozoites is completed within the hepatocyte, the parasites egress into the bloodstream where they infect erythrocytes, initiating the symptomatic phase of malaria.
Rodent models of malaria have been used to develop an important understanding of how sporozoites transmigrate through mammalian cells as they navigate from the skin to the liver and infect hepatocytes (reviewed by Menard et al., 2013) . During this journey, the sporozoite encounters a variety of host cells and cellular barriers, which it overcomes using the remarkable process of cell traversal. The ability to actively move through cells was first described during the study of sporozoite-macrophage interactions (Vanderberg & Stewart, 1990) .
Further research has determined that traversal involves dermal fibroblasts and lymphocytes (Amino et al., 2006; Amino et al., 2008; Coppi et al., 2007) , Kupffer cells (Frevert et al., 2005; Ishino, Yano, Chinzei, & Yuda, 2004; Tavares et al., 2013) , sinusoidal endothelial cells , and hepatocytes (Frevert et al., 2005; Ishino et al., 2004; Mota et al., 2001 ).
Far less is known about cell traversal by malaria sporozoites that cause disease in humans. Important differences have been reported between different Plasmodium spp., highlighting the need to study human malaria parasites where possible (Kaushansky & Kappe, 2011; Silvie et al., 2006) . Although P. falciparum sporozoites traverse human macrophages and hepatocytes in vitro (Behet et al., 2014; Dumoulin et al., 2015;  van Schaijk et al., 2008; , there is a paucity of knowledge surrounding the molecular basis for these events (reviewed by Yang & Boddey, 2017) . Recently, it was shown that GAPDH on the sporozoite surface interacts with CD68 on Kupffer cells to facilitate traversal through the macrophages (Cha, Kim, Pandey, & JacobsLorena, 2016) and that SPECT and PLP1 are essential for P. falciparum traversal of hepatocytes .
It is currently unclear why sporozoites traverse hepatocytes before productively infecting them. However, the concentration of heparan sulfate proteoglycans on the host cell surface is a key determinant that signals sporozoite to switch from traversal to invasion and the parasite's decision to change takes time (Coppi et al., 2007) .
Invasion of hepatocytes by P. falciparum, Plasmodium berghei, and Plasmodium yoelii sporozoites involves the conserved 6-Cys proteins, P36 and P52. Genetic disruption of the genes encoding them results in sporozoites that either cannot enter hepatocytes (Ishino, Chinzei, & Yuda, 2005) or in parasites that developmentally arrest soon after entry as they do not produce a parasitophorous vacuole (Labaied et al., 2007; VanBuskirk et al., 2009 ). Recently, P36 was shown to bind the hepatocyte surface protein Ephrin A2 receptor to facilitate the formation of the parasitophorous vacuole (Kaushansky et al., 2015) .
However, it is believed that other sporozoite proteins also contribute to hepatocyte invasion.
In this study, we have investigated the role of two conserved parasite proteins, apical merozoite antigen 1 (AMA1) and merozoite apical erythrocyte-binding ligand (MAEBL), both of which play important roles at different stages of the Plasmodium life cycle. AMA1 is a merozoite protein stored in micronemes and secreted to the parasite surface (Healer, Crawford, Ralph, McFadden, & Cowman, 2002) where it plays an important role in erythrocyte invasion (Anders et al., 1998; Thomas, Deans, Mitchell, Alderson, & Cohen, 1984; Triglia et al., 2000) . AMA1 cannot be genetically disrupted and is essential in blood stages of different Plasmodium species (Bargieri et al., 2013; Giovannini et al., 2011; Triglia et al., 2000) . In P. falciparum, AMA1 can be blocked by inhibitory peptides such as R1 (Harris et al., 2005; Harris et al., 2009 ). This peptide binds the AMA1 hydrophobic pocket (Richard et al., 2010) and prevents RON2 binding (Tonkin et al., 2011) . R1-treated merozoites can attach strongly to erythrocytes and deform them but cannot invade the cells (Harris et al., 2005; Richard et al., 2010; Riglar et al., 2011) . This suggests that AMA1 is involved in invasion after initial attachment and reorientation, likely in establishing the tight junction (Srinivasan et al., 2011) . The AMA-RON interaction has been shown to be an attractive target for therapeutic intervention (Srinivasan et al., 2014) .
AMA1 is abundantly expressed in sporozoites (Giovannini et al., 2011; Lindner et al., 2013; Silvie et al., 2004) . While conditional disruption of AMA1 in the rodent malaria parasite P. berghei had no effect on cell traversal activity or hepatocyte invasion (Giovannini et al., 2011) , anti-AMA1 monoclonal antibodies strongly reduced hepatocyte invasion by P. falciparum sporozoites (Silvie et al., 2004) . The reason for this discrepancy has not been resolved experimentally but, in addition to different host tropism, may involve functional redundancy by other parasite proteins (reviewed in Harvey, Yap, Gilson, Cowman, & Crabb, 2014 .
MAEBL is a chimeric protein with an AMA-like N-terminus and a C-terminus similar to erythrocyte-binding antigen 175 (EBA175; Kappe, Noe, Fraser, Blair, & Adams, 1998) . MAEBL is conserved in Plasmodium spp. and clusters phylogenetically with AMA4 of Toxoplasma gondii (Parker et al., 2016) . While MAEBL can bind erythrocytes (Kappe et al., 1998) , genetic disruption had no effect on blood-stage growth, indicating it is not solely essential for erythrocyte invasion (Fu et al., 2005; Kariu, Yuda, Yano, & Chinzei, 2002; Saenz, Balu, Smith, Mendonca, & Adams, 2008) . In contrast, MAEBL-deficient sporozoites cannot invade mosquito salivary glands (Kariu et al., 2002; Saenz et al., 2008) . Two isoforms of MAEBL are expressed in sporozoites as a result of alternate splicing of the 3′ exons , and the transmembrane isoform is essential for P. falciparum sporozoites to invade salivary glands (Saenz et al., 2008) . The fact that MAEBL is also synthesized by salivary gland sporozoites suggests it may have a function during interactions with the mammalian host. In support of this hypothesis, antibodies specific to both MAEBL isoforms strongly impair P. falciparum sporozoite invasion of hepatocytes (Peng et al., 2016) and antibodies against P. yoelii MAEBL also reduce hepatocyte entry .
However, direct genetic evidence for such a role has not been reported.
Here, we use an inhibitor combined with molecular genetics to investigate the function of AMA1 and MAEBL in P. falciparum sporozoites. Our data indicate that both proteins play important functions in P. falciparum during infection of human hepatocytes.
2 | RESULTS 2.1 | R1 peptide reduces P. falciparum cell traversal activity and hepatocyte entry AMA1 is a micronemal protein in merozoites (Healer et al., 2002) and sporozoites (Silvie et al., 2004) . Because the PfAMA1 gene cannot be directly disrupted (Triglia et al., 2000) , we studied the role of this protein in sporozoites using R1 peptide (Harris et al., 2005) . To investigate cell traversal, salivary gland sporozoites of the strain NF54, the parent of 3D7, were incubated with HC-04 hepatocytes in the presence of fluorescein isothiocyanate (FITC)-dextran and increasing concentrations of R1 peptide. We observed that cell traversal activity by sporozoites was significantly reduced in the presence of R1 peptide in a dose-dependent manner, ranging from 9.0 ± 0.9% inhibition at 0.1 mg/ml to a maximum of 61.0 ± 3.0% inhibition at 1.0 mg/ml (P < 0.0290; Figure 1a ). This corresponded to 50% inhibition of cell traversal using 0.7 mg/ml. In contrast, addition of R1 scrambled peptide control had no significant effect on cell traversal (Figure 1a ).
This demonstrates that R1 peptide significantly reduces cell traversal activity by P. falciparum NF54 sporozoites.
The primary effect of R1 peptide on merozoites is inhibition of invasion into erythrocytes, so we tested whether it has such an effect on sporozoite invasion into hepatocytes. The number of intracellular and extracellular sporozoites following treatment with R1 peptide or R1 scrambled peptide was quantified by immunofluorescence microscopy of differentially labelled parasites (Renia et al., 1988) . The number of sporozoites inside hepatocytes was reduced by 59 ± 0.1% by R1 peptide at 1.0 mg/ml relative to dimethyl sulfoxide (DMSO) (P = 0.0025) while R1 scrambled peptide did not significantly affect entry (P = 0.0732; Figure 1b ). The reduction in hepatocyte entry represents a similar degree of inhibition to that observed for cell traversal (Figure 1 ). To investigate whether R1 peptide affects sporozoite motility, we performed gliding motility assays with salivary gland sporozoites (Stewart & Vanderberg, 1988) . This revealed no significant Therefore, R1 peptide reduces cell traversal and invasion into hepatocytes, consistent with AMA1 playing an important role during these processes.
In merozoites, R1 peptide prevents AMA1 binding to the RON complex by outcompeting the RON2 binding site (Tonkin et al., 2011) . Some members of the RON complex are also expressed in sporozoites (Lindner et al., 2013; Risco-Castillo et al., 2014; Tufet-Bayona et al., 2009) . To examine expression and subcellular localization of the RON complex in P. falciparum sporozoites, we performed immunofluorescence microscopy using antibodies to RON4, an important member of the merozoite RON complex (Riglar et al., 2011) . RON4 expression was detected at the apex of sporozoites in two puncta ( Figure 1d) consistent with the rhoptries observed in RON4-labelled merozoites (Riglar et al., 2011) . Several sporozoites showed RON4 immediately extracellular to the parasite, suggesting it was secreted as the parasite was interacting with the host cell (Figure 1d ) as is observed with merozoites (Riglar et al., 2011) . Thus, an important member of the merozoite RON complex that is involved in erythrocyte invasion is expressed by P. falciparum sporozoites and secreted from rhoptries when the parasite is in close association with hepatocytes.
Taken together, these experiments show that RON4 is expressed in P. falciparum sporozoites and that an inhibitory AMA-binding peptide reduces sporozoite cell traversal activity and invasion of hepatocytes, suggesting that AMA1 plays important role in infectious sporozoites.
| Generation of P. falciparum parasites lacking the AMA-like protein MAEBL
In Toxoplasma, four AMA1 and three RON2 paralogs can mediate host cell invasion. It is currently not known if Plasmodium spp. express multiple AMA-RON proteins. However, the incomplete inhibition of cell traversal and hepatocyte invasion by R1 peptide raised the possibility that another protein may facilitate these functions in sporozoites, and our attention was directed to the AMA-like protein MAEBL. Plasmodium sporozoites abundantly express both AMA1 (Silvie et al., 2004) and MAEBL (Kappe et al., 1998) . The M1 and M2 domains of MAEBL share similarity with AMA1 in P. falciparum (Blair, Kappe, Maciel, Balu, & Adams, 2002) , and we determined this to be 29.8% similarity using P. falciparum strain 3D7 genome sequence data ( Figure S1 ).
To investigate the possible role of MAEBL in sporozoitehepatocyte interactions, we generated P. falciparum NF54 parasites in which the MAEBL gene was disrupted by double-crossover homologous recombination so that neither the transmembrane nor soluble isoform would be expressed (Figure 2a The asexual intraerythrocytic growth rate of each MAEBL knockout clone was evaluated. No difference relative to NF54 was observed ( Figure 3a ) as shown previously in P. berghei and P. falciparum (Fu et al., 2005; Saenz et al., 2008) . Parasites were differentiated to gametocytes and fed to Anopheles stephensi mosquitoes. No difference in the number of mature gametocytes (Figure 3b ), mosquito midgut oocysts (Figure 3c ), or hemolymph sporozoites ( Figure 3d ) was observed compared to NF54, consistent with previous P. falciparum data (Saenz et al., 2008) . However, a severe defect was apparent when salivary gland sporozoites were quantified (P = 0.0003; Figure 3e ).
These results agree with previous reports that MAEBL is essential for invasion of mosquito salivary glands by P. berghei and P. falciparum sporozoites (Kariu et al., 2002; Saenz et al., 2008) .
Collectively, these results confirm that the PfMAEBL locus was successfully disrupted, resulting in mutant sporozoites that behave as reported previously. reduction compared to NF54 (P < 0.001), which was similar to the background levels obtained with media alone (87% less dextran uptake than NF54; Figure 4c ). This shows that P. falciparum sporozoites isolated from hemolymph do not differ significantly in their cell traversal capability on different days of extraction and, importantly, that MAEBL is required for traversal of hepatocytes.
| MAEBL is required for P. falciparum sporozoite traversal of human hepatocytes
To determine whether disruption of PfMAEBL affected gliding motility, circumsporozoite protein (CSP)-positive trails on coverslips were quantified using hemolymph-derived sporozoites. The parasites were actively motile, and no significant difference was observed between NF54 and ΔMAEBL sporozoites (Figure 4d ). Taken together, these results demonstrate that MAEBL is required for cell traversal activity but not gliding motility by P. falciparum sporozoites.
| MAEBL plays an important role in P. falciparum sporozoite invasion of hepatocytes
To investigate whether MAEBL is involved in sporozoite invasion of hepatocytes, sporozoites were incubated with HC-04 cells for 3 or 48 hr before the number of intracellular parasites was quantified by immunofluorescence microscopy using differential surface labeling of intracellular and extracellular parasites. At both time points, the number of intracellular ΔMAEBL parasites was reduced by approximately 80% compared to NF54 (P < 0.0160; Figure 5c ) demonstrating a severe defect in host cell entry. Interestingly, the proportion of intracellular NF54 parasites at 48 hr was significantly less than at 3 hr (Figure 5a,b) .
While this could be partly attributed to hepatocyte proliferation (3.7-fold increase; P = 0.0043; Figure 5c ), it suggested that parasites might also be dying. To allow for direct comparisons of parasite numbers between time points, we analyzed the total number of intracellular parasites per well. This revealed that intracellular parasite numbers decreased significantly between the two time points (NF54 had 47% reduction; P = 0.0025), suggesting that a subset of intracellular sporozoites at 3 hr could not develop into exoerythrocytic forms (EEFs), as expected. Importantly, the number of ΔMAEBL parasites relative to NF54 parasites was significantly less at both time points (82-89% reduction at 3 hr, P < 0.0026 and 73-78% reduction at 48 hr, P = 0.0079; Figure 5d ). Collectively, this shows that P. falciparum sporozoites lacking MAEBL are severely impaired for hepatocyte invasion, consistent with an important role for this protein in infection of hepatocytes.
To assess the function of MAEBL during hepatocyte infection in vivo, homozygous urokinase plasminogen activator-severe combined immunodeficiency (uPA +/+ -SCID) mice transplanted with primary human hepatocytes to regenerate chimeric human livers (Mercer et al., 2001) were coinfected intravenously with NF54 and ΔMAEBL sporozoites isolated from hemolymph. While all mice had approximately equal human chimerism, coinfection of the same mice was employed as a strategy to reduce potential differences in infectivity between mice. The parasites were provided a further 6 days to differentiate into exoerythrocytic forms (EFF) and amplify their nuclear DNA before parasite liver load was measured in each mouse by quantitative real-time polymerase chain reaction (qRT-PCR). We followed the same protocol published previously, which reported the detection of 1 infected hepatocyte in 25% of whole liver (Foquet over, expression of CD81 in human hepatocytes is sufficient to allow P. yoelii sporozoites to invade but is not sufficient for P. falciparum invasion (Silvie et al., 2006) . Another example is the activation of the host receptor tyrosine kinase MET by P. berghei sporozoites during cell traversal to promote the development of EFFs (Carrolo et al., 2003) and inhibit hepatocyte apoptosis (Leiriao et al., 2005) . This does not occur during cell traversal by P. falciparum or P. yoelii sporozoites (Kaushansky et al., 2015) . Therefore, our approach was to use the human malaria parasite P. falciparum to investigate the function of AMA1 and MAEBL Values were normalized to a series of pretested standards and are mean ± standard deviation. Human chimerism in each mouse was determined to be (29%, 26%, and 25%) by quantitative polymerase chain reaction using oligonucleotides specific to human and mouse PTGER2 in sporozoites. This revealed important roles for both proteins during cell traversal and during parasite invasion of hepatocytes.
R1 peptide is a specific inhibitor of AMA1 in P. falciparum 3D7 merozoites that prevents erythrocyte invasion. This inhibitor caused a strong reduction in cell traversal activity and invasion of human hepatocytes by NF54 sporozoites, suggesting that AMA1 is important for both processes. The concentration required to inhibit cell traversal by 50% was higher than that reported previously for merozoite invasion (Harris et al., 2005 Risco-Castillo et al., 2014; Risco-Castillo et al., 2015) . However, our observations provide evidence that at least one member of the RON complex is secreted by P. falciparum sporozoites as they interact with hepatocytes, as would be expected during invasion.
The timing of invasion arrest for R1 peptide-treated merozoites occurs after attachment to the host cell (Richard et al., 2010; Riglar et al., 2011) . This suggests that AMA1 plays a key role in establishing the tight junction (Riglar et al., 2011; Srinivasan et al., 2011) , a hypothesis strongly supported by additional studies of AMA-RON binding in Toxoplasma , Tyler & Boothroyd, 2011 . Another hypothesis is that AMA1 is not required for tight junction but is important for attachment to the host cell and/or reorientation (Giovannini et al., 2011) . In our experiments, R1 peptide-treated sporozoites still attached to hepatocytes, suggesting that this peptide does not directly interfere with parasite adherence to HC-04 hepatocytes but affects a downstream step. The precise point will require further detailed investigation.
Recently, it was shown that approximately 50% of P. yoelii sporozoites traverse hepatocytes using a transient vacuole (Risco-Castillo et al., 2015) . While it is not known whether P. falciparum sporozoites also produce a transient vacuole, if so, perhaps R1 peptide inhibits their formation. This could explain the residual traversal observed in our study in the presence of R1 peptide, as the sporozoites could still traverse using the alternate pathway of rupturing the host cell membrane upon entry (Mota et al., 2001; Risco-Castillo et al., 2015) . The observation of transient vacuole formation during the entry step of traversal raises the possibility that traversal and invasion involve that same, or very similar, entry steps but different egress steps. This idea is consistent with AMA1 and MAEBL playing a role in both processes, as suggested by this study. The development of tools to study P. falciparum traversal by high-resolution live imaging is needed to further address this question.
The function of AMA1 in sporozoites has been studied previously using genetics approaches that targeted and disrupted either the AMA1 gene or 3′ untranslated region in P. berghei. These studies showed that AMA1 has an important function in P. berghei merozoite attachment to erythrocytes but plays no role in hepatocyte infection (Bargieri et al., 2013; Giovannini et al., 2011) .
This raises the question of why, if AMA1 is dispensable in sporozoites, is it expressed so abundantly? In P. falciparum, anti-AMA1 antibodies strongly reduce sporozoite invasion of human hepatocytes, suggesting that it is important for liver infection by this particular parasite species (Silvie et al., 2004) . One explanation for the discordant results is the inability to generate a pure population of P. berghei AMA1-deficient sporozoites (Bargieri et al., 2013; Giovannini et al., 2011) . As the authors noted, it could not be excluded that AMA1-deficient parasites were able to exhibit a normal phenotype because of the availability of low amounts of AMA1 in some parasites.
Another plausible explanation is functional redundancy of AMA mediated by one or more other proteins (reviewed in Harvey et al., 2014) . In Toxoplasma and other apicomplexans, three additional AMA1 paralogs and a further two RON2 paralogs facilitate invasion (Lamarque et al., 2014; Poukchanski et al., 2013) . It is therefore possible that Plasmodium spp. also utilize AMA and/or RON paralogs to interact with host cells, particularly because they also interact with a variety of host cells during their life cycle.
One candidate for an AMA1 paralog in Plasmodium spp. is the chimeric protein MAEBL (Kappe et al., 1998) . While AMA1 and MAEBL are not identical, they share similarity and are evolutionarily related (Kappe et al., 1998; Parker et al., 2016) . MAEBL-deficient P. berghei and P. falciparum sporozoites show a striking defect during invasion of mosquito salivary glands (Kariu et al., 2002; Saenz et al., 2008) , a finding that was also confirmed in our study. Like AMA1, MAEBL's precise function during invasion of salivary glands is not yet known. In our study, we sought to investigate whether MAEBL is also involved in sporozoite infection of hepatocytes. Rather than mechanically liberate sporozoites from the midgut as reported previously (Kariu et al., 2002) , we isolated sporozoites from the mosquito hemolymph following normal egress of sporozoites from oocysts. NF54 hemolymph sporozoites were motile, and their cell traversal activity remained stable over consecutive days. The hemolymph sporozoites also invaded HC-04
hepatocytes. However, genetic loss of MAEBL caused a profound loss of cell traversal activity and hepatocyte invasion into HC-04 cells yet had no effect on gliding motility. This provides direct genetic proof that MAEBL has an important role during human hepatocyte infection as suggested previously through the use of inhibitory antibodies (Peng et al., 2016; Preiser et al., 2004) . This was confirmed in vivo using humanized mice with chimeric livers, where MAEBL-deficient P. falciparum sporozoites were severely attenuated for liver infection.
Although sporozoites are far more infectious for hepatocytes after they reach salivary glands (Ball & Chao, 1961; Sultan et al., 1997) , they do not have to invade these glands to be infectious, and priming can even begin in the hemolymph (Kariu et al., 2002; Sultan et al., 1997; Vanderberg, 1975) . Our study of P. falciparum NF54 hemolymph sporozoites detected infection of hepatocytes in humanized mice with approximately 10 3 -fold less efficiency than when we used salivary gland sporozoites . This difference is similar to that reported previously for P. berghei (Sultan et al., 1997) . Nonetheless, our current study has revealed a >600-fold reduction in hepatocyte infectivity in vivo when MAEBL expression was disrupted, in agreement with our in vitro data, and the previous work of others (Peng et al., 2016; Preiser et al., 2004) that MAEBL is important for hepatocyte infection.
The role of MAEBL in liver infectivity of rats has been assessed using P. berghei sporozoites, which showed that midgut sporozoites did not require MAEBL for liver infection (Kariu et al., 2002) . It is unclear whether that was a P. berghei-specific phenotype or the result of isolating sporozoites from midguts, or due to another reason.
However, our body of results with P. falciparum hemolymph sporozoites was highly reproducible and statistically significant, and our conclusions are based on these data.
HC-04 cells (Sattabongkot et al., 2006) have been a useful model to examine human liver-stage biology, because it is the only human hepatocellular carcinoma line that supports complete development of P. falciparum, albeit at low infection efficiencies. We have investigated sporozoite-hepatocyte interactions using HC-04 cells and humanized mice with P. falciparum and shown that AMA1 and MAEBL have important roles during cell traversal activity and infection of liver cells. The significance of both proteins at disparate stages of the parasite's life cycle suggests that shared components of the attachment/invasion machinery may be utilized by different zoite forms to enter cells of human and mosquito hosts. It is known that several steps precede merozoite invasion of erythrocytes, such as primary attachment and reorientation of the parasite, followed by irreversible attachment and junction formation before ultimately ending in the encasement of the invaded merozoite with a parasitophorous vacuole membrane (Beeson et al., 2016) . It is not year clear whether sporozoite invasion of hepatocytes also follows a similar pattern. If so, the data shown here do not allow us to pinpoint exactly where AMA1 and MAEBL act in this cascade or even if they are involved in the same step. However, it is possible that both proteins are part of a group of proteins such as members of the 6-Cys family, P52 and P36 (Ishino et al., 2005; Kaushansky et al., 2015; Labaied et al., 2007; VanBuskirk et al., 2009) , that act together to mediate successful invasion of hepatocytes.
| EXPERIMENTAL PROCEDURES

| Parasite maintenance
The asexual stages of P. falciparum strain NF54 were maintained in human type O-positive erythrocytes (Melbourne Red Cross) at 4%
hematocrit. RPMI-HEPES media supplemented with 10% heat inactivated human serum (Melbourne Red Cross) were used to maintain the parasites at 37°C in 94% N, 5% CO 2 , and 1% O 2 . Sexual forms of the parasite were generated for transmission to mosquitoes using the "crash" method as previously described (Saliba & Jacobs-Lorena, 2013 ).
| Transgenic parasites
P. falciparum NF54 was used to generate all transgenic parasites used in this study. To generate the MAEBL knockout construct, 5′ and 3′
flanks of the locus were cloned into pCC1 using SacII/SpeI (5′ flank) and EcoR1/AvrII (3′ flank). Primers for amplication of PfMAEBL (PF3D7_1147800) were as follows: forward primer 5′-GAAGAAGAA AGAGACGTACTTTCAG-3′ and reverse primer 5′-CTTCATGTGTT CCTATAATTACAC-3′ (5′ flank); forward primer 5′-GTTCGATTCCG AAATAAAAGAAGTTG-3′ and reverse primer 5′-CAGGAGTATCA GTACTATTCCTGCTC-3′ (3′ flank). Purified plasmid DNA (80 μg) was transfected into ring-stage NF54 and selected using 5nM WR92210.
Lines were cloned by limiting dilution, and genotypes assessed by Southern blot using the digoxigenin kit from Roche, according to manufacturer's instructions.
| Asexual blood-stage growth assay
Highly synchronous trophozoite-stage parasites were diluted to 0.5% parasitemia at 2% hematocrit, and this was confirmed by flow cytometry (FACSCalibur; BD) using ethidium bromide (10 μg/ml; BioRad; Sleebs et al., 2014) . 
| Mosquito infection and analysis of parasite development
Five-to seven-day-old female Anopheles stephensi mosquitoes were provided a blood meal containing asynchronous gametocytes, diluted to 0.3-0.6% stage V gametocytemia. Mosquitoes were sugar starved for 16-24 hr before bloodfeeding and another 48-hr post-feeding to select the bloodfed females from a mixed mosquito population. Surviving mosquitoes were provided sugar cubes and water (via cotton wick) ad libitum. Oocysts were quantified from midguts isolated from cold-anesthetized and ethanol-killed mosquitoes 7-8 days post-blood meal and stained with 0.1% mercurochrome in water.
Hemolymph-derived sporozoites were isolated at Days 14-16 post-blood meal by perfusion of the mosquito thorax using 100 μl of RPMI HEPES media with a 29G needle, collecting the flow through in 1 ml tubes. Salivary glands were dissected in RPMI HEPES media from mosquitoes on Days 15-18 post-blood meal, and sporozoites were liberated using pestles and filtered through glass wool.
| Hepatocyte culture
HC-04 hepatocytes (Sattabongkot et al., 2006) were maintained in Iscove's Modified Dulbecco's Medium, supplemented with 5% heat-inactivated fetal bovine serum at 37°C in 5% CO 2 . Cells were split 1:6 every 2-3 days, once they reached~90% confluency.
| Cell traversal assay
The traversal activity of sporozoites was measured using the standard cell-wounding assay described in (Dumoulin et al., 2015) . for 20 min at room temperature (RT) and processed as described (Renia et al., 1988) . Briefly, sporozoites were detected by immunofluorescence staining using mouse monoclonal antibodies against PfCSP (1:1000) and goat anti-mouse Alexa 488 secondry antibodies by intrasplenic injection and engraftment was confirmed 8 weeks post-transplantation by analysis of serum human albumin (Mercer et al., 2001 ). An inoculum of 2.4 × 10 5 P. falciparum NF54 sporozoites and 2.4 × 10 5 ΔMAEBL F11 sporozoites freshly isolated from mosquito hemolymph was injected by intravenous tail injection into the same three humanized mice. Livers were obtained 6 days postinfection from CO 2 -euthanized mice, and individual lobes were cut as described (Foquet et al., 2013) . Lobes were pooled and emulsified into a singlecell suspension and flash frozen in liquid nitrogen for subsequent gDNA extraction.
| Measuring exoerythrocytic development in humanized mice
To quantify parasite load in the chimeric livers, gDNA was isolated from the single-cell liver suspensions, and Taqman probe-based quantitative PCRs were performed as previously described (Alcoser et al., 2011; Foquet et al., 2013; . To specifically differentiate NF54 from ΔMAEBL genomes from the same mouse samples, the following oligonucleotides were used: For NF54
genomes: MAEBL_F (5′-GAATGGCAAAAGGAAGGTGA-3′) and MAEBL_R (5′-GTGCCCTCCCTTCATAAACA-3′) that bind internal to the MAEBL gene in NF54 but do not amplify a product using ΔMAEBL parasites. For ΔMAEBL genomes: hDHFR_F (5′-ACCTAATAGAAATA TATCAGGATCC-3′) and hDHFR_R (5′-GTTTAAGATGGCCTGG GTGA-3′) that bind in the hDHFR cassette in ΔMAEBL parasites but do not amplify a product using NF54. Human and mouse genomes were quantified using oligonucleotides specific for prostaglandin E receptor 2 (PTGER2) from each species, as described (Alcoser et al., 2011) . All 
| Statistics
All statistics were performed using the Mann-Whitney nonparametric test in Graphpad Prism 6. 
| Availability of data and materials
All data generated or analyzed during this study are included in this published article and its Supporting Information files.
